Histopathologic features of inflammatory bowel disease are associated with different CD4+ T cell subsets in colonic mucosal lamina propria by Iacucci, Marietta et al.
 
 
University of Birmingham
Histopathologic features of inflammatory bowel
disease are associated with different CD4+ T cell
subsets in colonic mucosal lamina propria
Iacucci, Marietta; Gui, Xianyong; Li, Ji; Ueno, Aito; Qian, Jiaming; Ghosh, Subrata
DOI:
10.1093/ecco-jcc/jjy116
10.1093/ecco-jcc/jjy116
License:
Other (please specify with Rights Statement)
Document Version
Peer reviewed version
Citation for published version (Harvard):
Iacucci, M, Gui, X, Li, J, Ueno, A, Qian, J & Ghosh, S 2018, 'Histopathologic features of inflammatory bowel
disease are associated with different CD4+ T cell subsets in colonic mucosal lamina propria', Journal of Crohn's
& Colitis. https://doi.org/10.1093/ecco-jcc/jjy116, https://doi.org/10.1093/ecco-jcc/jjy116
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 03/09/2018
This is the accepted manuscript for a forthcoming publication in Journal of Crohn's & Colitis.
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Ac
ce
pte
d M
an
us
cri
pt
Manuscript Doi: 10.1093/ecco-jcc/jjy116 
Copyright © 2018 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University 
Press. All rights reserved. For permissions, please email: journals.permissions@oup.com 
Title: 
Histopathologic Features of Inflammatory Bowel Disease are Associated with  
Different CD4+ T Cell Subsets in Colonic Mucosal Lamina Propria 
Authors and Institutions: 
Xianyong Gui
a#*
,
 
Ji Li
#b,c
, Aito Ueno
b
, Marietta Iacucci
b,d
, Jiaming Qian
c
, Subrata Ghosh
b,d
 
a. Department of Pathology and Laboratory Medicine, University of Calgary, and Calgary 
Laboratory Services, Calgary, Alberta, Canada 
b. Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada 
c. Department of Gastroenterology, Peking Union Medical College Hospital, Beijing, China 
d. Institute of Translational Medicine, University of Birmingham, Birmingham, United Kingdom  
 # Co-First author (with equal contribution), *Corresponding author 
Contact Information of corresponding author: 
Dr. Xianyong Gui 
Department of Pathology and Laboratory Medicine 
University of Calgary 
1403 29
th
 St NW 
Calgary, Alberta T2N 2T9 
Canada 
Email: xgui@ucalgary.ca 
Tel: +1-403-944-8507 
Fax: +1-403-944-4748 
Downloaded from https://academic.oup.com/ecco-jcc/advance-article-abstract/doi/10.1093/ecco-jcc/jjy116/5076882
by guest
on 27 August 2018
Ac
ce
pte
d M
an
us
cri
pt
Manuscript Doi: 10.1093/ecco-jcc/jjy116 
1 
 
ABSTRACT 
 
Background: Inflammatory bowel disease (IBD) results particularly from aberrance of CD4+ 
helper and regulatory T cells and is histopathologically chronic active enterocolitis with features 
reflecting both activity and chronicity of mucosal inflammation. The exact immunologic-histologic 
correlation is not understood.  
Methods: We studied the correlation between colonic mucosal CD4+ T cell subsets (Th1, Th2, 
Th17, Th22, and Treg) and mucosal histologic changes in ulcerative colitis (UC) and Crohn’s 
disease (CD). CD4+ T cell subtyping and enumeration were achieved by flow cytometry. 
Histologic features were categorized and semi-quantitated using three validated histological 
scoring schemes (ECAP, RHI, and D’Haens). Correlations between prevalence (%) of CD4+ T 
cell subsets and histologic scores were analyzed.  
Results: Treg cells were correlated with ECAP category A (activity) as well as RHI scores. Treg 
was particularly increased in mucosa with severe neutrophilic infiltration in cryptal/surface 
epithelium and in lamina propria, and with basal plasmacytosis. Th17 cells were also increased 
in cases with extensive neutrophil infiltrate in lamina propria, whereas RORc+ cells were 
increased in cases with severe lymphoplasmacytic infiltration in lamina propria. In both UC and 
CD, the mucosa with marked crypt architectural alteration had increased IL-22+ and Th22 cells. 
UC with Paneth cell metaplasia had higher Th17 cells. CD with granuloma had increased IL-22+ 
and IL-22+IFN-γ+ cells.  
Conclusions: Treg appears to be associated with the overall severity of IBD histopathology, 
particularly with active inflammation. Th17 is also associated with activity. Whereas IL-22+ cells 
are associated with chronicity and granuloma formation in CD.     
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1. Introduction 
The histopathology of inflammatory bowel disease (IBD), ulcerative colitis (UC) and Crohn’s 
disease (CD), is a chronic active inflammation of intestinal mucosa (enterocolitis), with shared 
and distinctive features. From the biologic perspective and for the purpose of practical clinical-
histopathological assessment, the various histologic changes in IBD are broadly categorized into 
‘activity’ and ‘chronicity’. Activity is characterized by active/acute  inflammation, i.e., neutrophil 
infiltration, of the glandular/cryptal epithelium (cryptitis and crypt abscess) and surface 
epithelium (erosion and ulceration), usually causing destructive damage of the epithelium, along 
with mixed neutrophilic and lymphoplasmacytic (mononuclear cell) infiltration in lamina propria 
with the latter one tending to persist (and thus regarded as chronic inflammation). Chronicity is 
primarily the subsequent histoarchitectural and cytologic alterations of glands secondary to 
epithelial injury following a prolonged and repetitive active and chronic inflammation, and it is 
featured mainly by the cryptal architectural alteration/distortion (including disorganized 
arrangement, variable shape and size, shortening/dropout, and branching of crypts), along with 
villiform configuration of the surface epithelium as well as Paneth cell metaplasia (in left colon) 
and/or Paneth cell hyperplasia (in right colon and/or terminal ileum). None of these features is 
pathognomonic per se for IBD though.  
The key pathogenetic mechanism of IBD is the aberrant immunity of bowel mucosa, 
including both innate immunity and adaptive immunity, with involvement of gut microbiota and 
defects in gut barrier. The aberrant adaptive immunity is primarily T cell mediated, with 
fundamental defects of the CD4
+
 helper T (Th) cells and regulatory T (Treg) cells. Treg cells and 
different Th cell subsets, including Th1, Th2, Th17, Th22, defined by their production of 
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lineage-specific cytokines and functions, play a discriminatory role in translating certain antigen-
specific immune response into different tissue functions or pathology. In general, Th1 and Th2 
are primarily pro-inflammatory effectors, Treg helps to keep balance between inflammation and 
tolerance,
[1,2]
 Th17 has both pro-inflammatory and protective effects, whereas Th22 plays a role 
in epithelial regeneration and repairing.
[3]
 All of these CD4
+
 T cells also interplay with each 
other.  
It is reasonable to believe that the different histologic patterns of the mucosal inflammation 
and associated histomorphologic alterations of glandular epithelium in IBD may be associated 
with different immunologic mechanisms that involve different subsets/patterns of immune cells 
and cytokines. However, the exact histologic-immunologic correlation in IBD is not understood 
yet and has not been specifically studied. This study aims to explore the association between the 
key histopathological features of the activity and chronicity in IBD and the prevalence of CD4
+
 
T cell subsets in lamina propria, which would help us further understand the pathologic basis of 
IBD and possibly appreciate the pattern of histologic improvement in response to different 
targeted therapies in future studies. Such a study needs histopathological scoring that reflects 
both activity and chronicity as well as lamina propria T lymphocyte immunophenotyping. 
 
2.  Materials and Methods 
 
2.1.  Patient Cohort and Colonic Mucosal Tissue Samples  
53 patients with IBD (27 UC, 26 CD) were enrolled into the study from the University of 
Calgary IBD Clinic. For CD cases, only those with colonic involvement (i.e., Crohn’s colitis or 
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ileocolitis) were included and only the colonic mucosa tissues were studied, considering that 
there are differences between ileal and colonic mucosal immunity. The diagnoses and 
classification of UC or CD were made by specialized IBD clinicians (SG, MI) based upon the 
overall clinical, radiographic, endoscopic and histological findings, according to widely accepted 
criteria.
[4]
 
The patients’ data were extracted from their medical records and included demographic 
characteristics, extent of disease, endoscopic features, clinical and endoscopic assessments for 
the disease activity, and medication use (Table 1). 
The clinical disease activities of the patients’ symptoms were assessed using the total Mayo 
score for UC
[5]
 and Harvey-Bradshaw Index (HBI) for CD.
[6]
 UC patients were categorized by 
the total Mayo score into 3 groups: remission (score 0 to 2), mild (score 3 to 5), and moderate to 
severe (score ≥ 6). CD patients were categorized by HBI into 3 groups: remission (score 0 to 4), 
moderate (score 5 to 8), and severe (score ≥ 9). Furthermore, the endoscopic activity of UC and 
CD was assessed using Mayo endoscopic subscore
[5]
 and Simple Endoscopic Score for CD 
(SES-CD),
[7]
 respectively (assessed by MI). UC patients was categorized by Mayo endoscopic 
sub-score into 3 groups: remission/mild (score 0 and 1), moderate (score 2), and severe (score 3), 
while CD patients were categorized by SES-CD into 4 groups: remission (score 0 to 2), mild 
(score 3 to 6), moderate (score 7 to 16), and severe (score ≥ 17). The extent of disease 
involvement was assessed using the Montreal classification.
[8]
 UC patients were classified into 3 
groups as proctitis (E1), left-sided colitis (E2), and pancolitis (E3). CD patients were categorized 
into 2 groups as colitis (L2) and ileo-colonic CD (L3). 
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This study has been approved by the Conjoint Health Research Ethics Board of the University 
of Calgary (Control ID: REB14-2429). All enrolled patients were consented. 
 
2.2.  Histopathological Assessment 
Colonic mucosal biopsies were taken from the areas with visibly inflamed mucosa on endoscopy 
(for the majority of patients) or taken randomly when there was no visible inflammation, where 
the endoscopic scoring of disease activity was made. All endoscopic scoring and biopsies were 
taken by an expert IBD endoscopist (MI). The histopathologic changes seen in the biopsies were 
carefully evaluated on routine Hematoxylin and Eosin (H&E) stained slides, with all features 
being categorized and semi-quantitated independently by a gastrointestinal pathologist (XG), 
who was blinded to the clinical and endoscopic findings, using a newly developed (by XG) 
comprehensive histological scoring system built based on several published schemes
[9-14] 
with 
modification, which reflects all common histologic features of both active and chronic 
inflammation seen in IBD. The grading/scoring scheme, coined ECAP (Extent, Chronicity, 
Activity and Plus) system,
[15-17]
 covers the following aspects of IBD pathology: (1) Extent (E) of 
mucosal inflammation (focal, multifocal, or diffuse), (2) Chronicity (C): crypt architectural 
alteration and Paneth cell metaplasia or hyperplasia, (3) Activity (A) of colitis: degree of 
neutrophilic inflammation of cryptal/surface epithelium as well as lymphoplasmacytic and 
neutrophilic infiltration of lamina propria, and (4) Plus several other common but less 
understood and unclassified findings (P) including lamina propria eosinophilic infiltration, 
lymphoid follicles/aggregates, and granuloma (for CD patients only). The scheme for UC and 
CD are slightly different only on the assessment of disease extent (E). The details of the ECAP 
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system are shown in Table 2, including the specific criteria for inclusion into each of these 
grades. Examples of the key histologic features are displayed in Figures 1.  
The ECAP system has been successfully used by us in studies involving assessment of UC 
disease activity and severity, in which the ECAP scores showed nice concordance with high-
definition endoscopic findings and sensitivity in detecting minor histologic abnormalities in 
apparently normal mucosa.
[15-17]
 A preliminary validation was recently conducted on a separate 
group of 20 colonic biopsies of UC by three experienced gastrointestinal pathologists in different 
countries and showed a very good inter-observer agreement, with the intraclass correlation 
coefficients (ICC) being 0.8889 (95% CI 0.7621-0.9481) for the total ECAP scores. (unpublished 
data, please refer to Acknowledgments section.)  
As a comparison and further confirmation, two other well-known and widely accepted 
histological grading systems for IBD were also employed in parallel with ECAP scoring. For 
UC, the Robarts Histologic Index (RHI), another recently proposed and validated UC activity 
scoring scheme,
[18]
 was also determined, which can actually be easily derived from the ECAP-
category A scores (parameters of activity) in our ECAP scoring results [by using the formula: 
RHI = (A1-1) (when A1 >1) or A1 (when A1=1) x 5 + A2 x 3 + A5 + A7 x 2)].  For CD patients, 
the D`Haens score 
[19] 
was also obtained.  
 
2.3.  Immunologic Profiling of CD4
+
 T Lymphocyte Subsets in Colonic Lamina Propria  
The profiling and enumeration of the subsets of CD4
+ 
T lymphocytes in colonic mucosa were 
achieved by employing multicolor flow cytometry. Using the fresh tissue samples of colonic 
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mucosa that were half splatted from the same biopsies (taken from the same area and at the same 
time in the same colonoscopy procedure) that were sent to pathology laboratory for histological 
evaluation, the lamina propria mononuclear cells (LPMNCs) were isolated as previously 
described.
[20]
 Briefly, the epithelial cells were removed by agitated incubations with Ca
++
 and 
Mg
++
 free Hanks’ balanced salt solution (HBSS, Life Technologies Inc, Burlington, ON, 
Canada) containing 1 mM EDTA (Sigma-Aldrich, Burlington, ON, Canada) at 37℃. Then, the 
tissues were incubated in RPMI1640 cell culture media with L-glutamine (Life Technologies) 
containing 2.5% fetal bovine serum (Life Technologies), 1 mM dithiothreitol (Life 
Technologies), 100U/mL penicillin and 100μg/ml streptomycin (Life Technologies), and later 
incubated in the culture media containing 100IU/mL collagenase type IV (Life Technologies) for 
1 hour before mechanical dissociation using GentleMACS Dissociator (Miltenyi Biotec Inc, San 
Diego, CA). In the end, LPMNCs were collected after passing through a 40 μm cell strainer for 
flow cytometric analysis. 
The isolated LPMNCs (500,000 cells) were cultured in the presence of phorbol-12-myristate-
acetate (PMA, 5 μg/mL, Sigma-Aldrich) and ionomycin (5 nM, Sigma-Aldrich) for 1 hour 
followed by the addition of monensin (GolgiStop; BD Biosciences, Mississauga, ON, Canada) 
for another 16 hours. The harvested cells were incubated with LIVE/DEAD Fixable Dead Cell 
Stain Dye (Life Technologies) and fluorochrome-conjugated antibodies against the following 
surface markers: CD3 (clone OKT3, eBioscience, San Diego, CA, USA), CD4 (clone SK3, BD 
Biosciences), CD8 (clone RPA-T8, BD Biosciences), and CD25 (clone M-A251, BD 
Biosciences). After washing with PBS, cells were fixed and permeabilized using a Foxp3 
staining kit (eBioscience) according to the manufacturer’s instructions, followed by staining with 
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fluorochrome-conjugated antibodies against the following intracellular components: IFN-γ 
(clone 4S.B3, eBiosciences), IL-13 (clone JES10-5A2, BD Biosciences), IL-17A (clone N49-
653, BD Biosciences), IL-22 (clone 22URTI, eBioscience), T-bet (clone eBio4B10, 
eBioscience), Gata3 (clone TWAJ, eBioscience), RORc (clone AFKJS-9, eBioscience), FoxP3 
(clone 259D/C7, BD Biosciences) and isotype controls. The different distinct CD4
+ 
T cell 
subsets were defined by their expression of specific cytokines and master transcription factors: 
(1) IFNγ+ or T-bet+ for Th1, (2) IL-13+ or Gata3+ for Th2, (3) IL-17A+ or RORc+ for Th17, (4) a 
combination of IL-22
+
/ IFN-γ- / IL-17A- for Th22, and (5) CD25+ / Foxp3+ for Treg.  
A LSR II flow cytometer (BD Biosciences) was used to acquire samples and post-acquisition 
analysis was performed using FlowJo software (TreeStar, Inc., Ashland, OR) using a gating 
strategy with doublet and dead cell discriminations as previously described
[20]
 and exampled in 
Figure 2. The flow cytometry data were initially treated blindly from all clinical-endoscopic-
histologic diagnoses. 
 
2.4.  Statistical Analysis 
Continuous variables are shown as the mean (±SD). The probability of significant difference 
between two groups was calculated using Mann-Whitney test and chi−squared test for 
continuous and categorical variables, respectively. Statistical significances of ECAP total scores 
and subcategory scores were determined by performing ANOVA analysis and Bonferroni 
comparisons test and Kruskall-Wallis test for post-tests comparing each severity group. 
Spearman’s rank order correlation coefficients (Spearman’s rho) and the p values were 
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calculated to compare likelihoods of ECAP score and T helper cell subsets. Data were collected 
in a Microsoft Excel database (Microsoft Excel 2010; Microsoft Corp., Seattle, WA, USA) and 
statistically analyzed using SPSS software for Windows, release 19.0 (SPSS Inc., Chicago, IL, 
USA) and Graphpad Prism 5.0 (Graphpad Inc., La Jolla, CA, USA). Significance was defined as 
a two-sided p value < 0.05.  
 
 
3. Results 
 
3.1.  Correlation between ECAP and RHI and between ECAP and D’Haens in Histological 
Scoring 
In the same group of UC cases, an excellent in-parallel correlation was shown between the total 
ECAP score and RHI score (γ = 0.893, p < 0.001) as well as between ECAP-category A score and 
RHI score (γ = 0.955, p < 0.001) (Figure 3). ECAP-category C score was not compared with RHI 
score, since the latter represents only the activity. 
In the same group of CD patients, an equally excellent correlation was demonstrated between the 
total ECAP score and D’Haens score (γ = 0.947, p < 0.001) as well as between ECAP-category A 
score and D’Haens score (γ = 0.914, p < 0.001) and between ECAP-category C score and D’Haens 
score (γ = 0.519, p = 0.007) (Figure 3).  
   
3.2. Association between Histological and Clinical-Endoscopic Assessments of Disease Activity 
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Based on the total Mayo clinical disease activity scores (which includes endoscopy), UC cases 
were categorized into 3 groups for further analysis. As compared with those in remission, the cases 
with moderate to severe activity showed significantly higher total ECAP scores (p < 0.05) and 
category A scores (p < 0.01).   
Similar relationship also existed between the ECAP scores and the Mayo endoscopic subscores, 
the patients with Mayo endoscopic score 3 group had significantly higher total ECAP scores (p < 
0.05) as well as higher category A scores (p < 0.01) in their colonic biopsies, as compared with 
those in Mayo endoscopic score 0-1 group.  
However, there was no significant correlation between the clinical or endoscopic severity of 
disease activity and the ECAP category C and category P scores in UC. (Data not shown). This 
suggests that the commonly used total Mayo score and Mayo endoscopic subscore reflect 
essentially the histologic activity but not the chronicity of UC.  
In CD patients, there was no significant correlation between total ECAP or any subcategory 
scores and either Harvey-Bradshaw disease activity index or SES-CD scores. In agreement with the 
ECAP scoring, CD D’Haens histology scores also failed to show correlation with the clinical and 
endoscopic scores in the same cases.  
 
3.3. Association between Histologic Changes and Prevalence of Specific CD4
+
 T Cell Subsets  
By analyzing the correlation between the ECAP scores and the prevalence/proportion of certain 
CD4
+
 T lymphocyte subsets in lamina propria, including Th1, Th2, Th17, Th22, and Treg cells, a 
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number of histologic-immunologic correlations were found to be significant. The different patterns 
of histopathology appeared to be correlated with different subsets of CD4
+
 T cells. 
First, Treg cells were associated with the active (i.e., neutrophilic) inflammation and the overall 
severity of histopathology. When looking at the total ECAP scores, as shown in Figure 4 (A, B, D, 
E), the proportion of Treg cells (i.e., CD25
+
FoxP3
+
CD4
+ 
T cells), but not any other T cell subsets, 
was weakly correlated with total ECAP scores in both UC (γ = 0.281, p < 0.01) and CD patients (γ 
= 0.274, p <0.01). Similarly, the prevalence of Treg cells was also significantly correlated with RHI 
score in UC patients (γ = 0.562, p = 0.003), and with D’Haens score in CD cases (γ = 0.501, p = 
0.019). These suggest a positive correlation between the prevalence of Treg cells and the overall 
severity of histologic abnormalities.  
When exploring the ECAP subcategory scores, the overall category A score and the proportion 
of Treg cells was correlated in both UC (γ = 0.276, p < 0.01) and CD patients (γ = 0.223, p < 0.05), 
as shown in Figure 4 (C and F). More specifically, the correlation was particularly seen between 
Treg and several elements of category A (activity), as shown in Figure 6. In UC, the proportion of 
Treg cells was particularly increased in the mucosa with more severe neutrophilic cryptitis (A2), 
crypt abscess (A3), and crypt destruction (A4), neutrophil infiltrate in lamina propria (A7), and 
with basal plasma ytosis (A6) (p < 0.05 for each). In CD, the prevalence of Treg was increased in 
mucosa with neutrophil infiltration in surface epithelium (A1) as compared with those with non-
inflamed surface epithelium (p < 0.05). All of the results indicate that the positive correlation 
between Treg and the disease severity primarily lies in the association of Treg with active 
inflammation (as also showed with RHI).  
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Second, Th17 cells (IL-17A
+
 or RORc
+ 
CD4
+
 T cells) were also associated with histologic 
activity and chronicity. In UC, the proportion of RORc
+
CD4
+
 T cells was increased in cases with 
more severe lymphoplasmacytic cell infiltration of lamina propria (A5) (p < 0.05). Moreover, the 
mucosa with Paneth cell metaplasia (C2) had a higher prevalence of IL-17A
+
CD4
+
 T cells as 
compared with the cases without Paneth cell metaplasia (p < 0.05), as shown in Figure 7. 
Third, IL-22
+
CD4
+ 
T cells and Th22 cells were associated with the histologic features of 
chronicity and the presence of granuloma in CD. As shown in Figure 8, in UC patients the mucosa 
with diffuse crypt architectural alteration (C1) had significantly increased proportion of IL-
22
+
CD4
+ 
T cells as well as Th22 (IL-22
+
IFN-γ-IL-17A-) cells, as compared with those with only 
focal crypt architectural alteration (p < 0.05, respectively). In CD patients the mucosa with diffuse 
crypt architectural alteration also had increased proportion of Th22 cells in lamina propria, as 
compared with those with only focal alteration (p < 0.05). Interestingly, CD cases with presence of 
epithelioid granuloma in colonic mucosa (P3) had significantly increased percentage of IL-
22
+
CD4
+ 
T cells as well as IL-22
+
IFN-γ+CD4+ T cells (a type of crossover CD4+ T cells as result of 
plasticity), as compared with those with absence of granuloma (p < 0.01 for both).  
 
4. Discussion 
In the immunopathology of IBD, one of the key mechanisms is the imbalance of CD4
+
 T cells 
that include primarily the IFN-γ-expressing Th1 cells, IL-4-secreting Th2 cells, Th17 cells that 
express IL-17A, IL-17F, and IL-22, and Th22 cells that express IL-22 but no IL-17A/F or IFN-γ. 
Some fundamental differences exist between UC and CD with regard to their characteristic 
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different patterns of cytokines and subsets of CD4
+
 T cells. UC has been defined as Th2-type 
disease and CD as Th1-like, based on their different abundance of Th1- or Th2-associated 
effector cytokines (predominantly IFN- γ and IL-12 for Th1, IL-4, IL-5, and IL-13 for Th2) in 
gut mucosa, as shown by us and other groups.
[20,22-24]
 Additionally, Th17 and Foxp3-expressing 
Treg cells, as well as IL-17A/Foxp3 double expressing CD4
+
 T cells, are also enriched in the 
lamina propria of IBD patients.
[ 1,21, 25,26]
 Th22, defined as IL-22 
+
IFN-γ-IL-17A- CD4+ T cells, 
was found to be depleted in gut mucosa of severe UC patients.
[27]
 Certain CD4
+
 T cell subsets are 
associated with the disease activity in IBD. Our own previous studies demonstrated that Th1 
cells in bowel mucosa and Treg cells in peripheral blood were positively correlated with the IBD 
disease activity assessed by clinical and endoscopic scores.
[18,26]
  Smids et al has revealed that 
the intestinal T-cell infiltrate associated with active IBD is composed of increased proportion of 
CD4
+
 cells, Tregs and central memory T cells (TCM).
[28]
 Our present study specifically and 
systemically correlates the histopathologic features of IBD with the lamina propria CD4
+
 T cell 
subsets, and we had some interesting observations regarding the histologic-immunologic 
association. Among the CD4
+
 T cells in mucosal lamina propria the Treg cells appeared to be 
positively associated with the increasing severity of active inflammation (i.e., neutrophilic 
inflammation) in both UC and CD patients. Th22 and Th17 cells appeared to be associated with 
the features of chronicity, with Th22 correlating with crypt architecture alteration and Th17 with 
Paneth cell metaplasia/hyperplasia. Furthermore, IL-22
+ 
Th cells seemed to be associated with 
the occurrence of epithelioid granuloma in CD patients.  
Our novel histological scoring scheme, ECAP system, was designed to fully reflect almost every 
component of the histopathology of IBD, including both active inflammation and chronic 
histocytologic changes. This approach has been proven in several of our studies to be concordant 
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with the finest endoscopic technology in assessment of the mucosal inflammation and mucosal 
healing in UC 
[15-17]
. Although it has not been widely validated, a preliminary validation process has 
shown an excellent inter-observer agreement. The parameters included in the category A contain all 
elements of the recently proposed and validated Robarts Histologic Index (RHI),
[18]
 and can be 
easily converted to RHI. Our ECAP total scores and subcategory A scores were found to be in 
excellent correlation with RHI, as shown in this and the other studies.
[17]
 Additionally, the ECAP 
scores, including the subcategory A and C scores, are in parallel to the D’Haens score in our study. 
The reliability and usefulness of our ECAP system was again proven. Admittedly, for CD cases the 
ECAP scores failed to show good concordance with the currently used clinical and endoscopic 
scoring schemes, as did the D’Haens score. The reasons may include the characteristic patchiness 
and focal and transmural nature of inflammation in CD, and the currently used HBI and SES-CD 
for assessment of CD may not be sensitive or reliable by the histological standard. Previous studies, 
using several different histological indices, also failed to demonstrate a histologic correlation with 
clinically or endoscopically assessed disease activity in CD.
[29-31]
 Nevertheless, we believe that the 
ECAP system still provides a reasonable method to semi-quantitate the major changes and the 
degree of mucosal inflammation in CD at the histologic level. 
Treg cells are crucial for the homeostasis of normal gut mucosal immunity. In active UC and 
CD, they are abundantly recruited to lamina propria and, in contrast, depleted in peripheral 
circulation. The pivotal role of Treg in the control of pro-inflammatory effects of effector T cells 
was found to be maintained in the setting of IBD, but meanwhile their protective function is 
compromised due to the gain of pro-inflammatory effect in IL-17
+
 FoxP3
+
 CD4
+
 T cells under 
certain cytokine environment,
[32]
 as it is well known that Treg cells under certain inflammatory 
conditions can lose suppressive function and acquire pathogenicity.
[33]
 We previously demonstrated 
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the abundance of the crossover population of Th17/Treg in peripheral or lamina propria 
compartments in IBD patients.
[21]
 Others found that the abundance of Treg cells in the mucosa with 
active UC was consistent with the disease activity assessed clinically and endoscopically and it 
could be modulated by the immunosuppressive medications and biologic agents.
[1,34, 35, 36]
 ) In this 
study, we further demonstrated that the Treg cells were closely associated with the overall 
histological abnormalities in IBD, primarily the active inflammation (i.e., neutrophil infiltration in 
glandular epithelium and lamina propria). Our study was not large enough to explore differences 
due to different drugs and this will require longitudinal studies which are ongoing.    
Th17 cells are mainly responsible for IL-17A production, which is known to exert dual effects in 
IBD, as a pro-inflammatory cytokine as well as a protective factor in the mucosal healing. Th17 and 
its cytokines IL-17A, IL-21, IL-22 were found increased in the involved gut mucosa in active IBD, 
and their increase were correlated with the disease activity assessed clinical-endoscopically.
[37]
 
Moreover, T17 plasticity, particularly along the Th1 - Th17 and Th17 - Treg axes, plays an 
important role in the pathogenesis of IBD.
 [38] 
In the current study, Th17 cells were found to be 
associated with lymphoplasmacytic infiltration in lamina propria in UC, one of the key 
histopathologic features of activity. This result demonstrates again the pro-inflammatory nature of 
Th17 cells, which is usually restrained by RORc
+
FoxP3
+
 regulatory T cells (iTreg) in the state of 
host defense, as revealed in animal studies.
[39]
 The concurrent increase of both IL-17A
+
CD4
+
 T 
cells and RORc
+
CD4
+
 T cells and their equal correlation with active inflammation, as seen in our 
results, are likely indicative of their changes toward a new balance between the two at a higher 
level.    
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Among Th subsets, Th1, Th17, and Th22 all produce IL-22, and subsets of Th cells co-
expressing IL-22/IFN-γ (as seen in our observation) and/or IL-22/IL-17 exist. Studies found 
depletion of IL-22
+
CD4
+
 T cells in colonic lamina propria in UC.
[27]
 We have also reported 
previously that the IL-22
+
CD4
+ 
T cells and Th22 cells decreased in UC.
[20]
 IL-22 also plays a 
crucial role in maintaining the epithelium integrity of mucosa and skin, while participating in 
inflammation,
[3]
 as its receptor is expressed only in epithelial cells.
[40]
 IL-22 and its downstream 
transcription factor STAT3 activation (IL-22/STAT3 signaling) were found to be two important 
mediators of intestinal epithelial host defense and wound healing during mucosal inflammation, 
which could induce the proliferation and reconstitution of mucosal epithelial cells, enhance goblet 
cells to regenerate and produce mucus-associated proteins, promote the remodeling of extracellular 
matrix and cell migration, and stimulate the production of antimicrobial peptides.
[41,42]
 Some 
investigators even proposed to consider the IL-22/STAT3 signaling as a potential therapeutic 
approach in promoting mucosal healing in IBD.
[43]
 In addition, a recent study found that human 
microbe-responsive γδ T cells can polarize colonic CD4+ T cells to become IL-22+ cells, thus 
promote IL-22 production and IL-22 inducible antimicrobial protein calprotectin secretion, as a 
mechanism of promoting mucosal barrier defence.
[44]
 In this study we observed that the crypt 
architectural alternation, a key feature of chronicity as well as reflection of glandular/cryptal 
epithelium restitution/regeneration, was associated with the IL-22
+
CD4
+
 T cells and Th22 cells. 
From the biological perspective, our finding may reflect the role of IL-22 and Th22 cells in bowel 
epithelial regeneration and mucosal healing.  
Paneth cells are unique specialized secretory epithelial cells known to play an important role in 
the innate host defense in normal intestinal mucosa through their secretion of antimicrobial peptides 
and proteins, e.g., α-defensins. Paneth cell metaplasia, defined as aberrant presence of any number 
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of Paneth cells in the distal colon (descending colon, sigmoid and rectum), is also a histologic 
indicator of chronic mucosal injury, particularly chronicity of IBD. Paneth cell hyperplasia 
(abnormally prominent, enlarged, in aggregates, and with prominent degranulation) in the proximal 
colon and terminal ileum seem to represent the same significance in the setting of IBD,
[41,45]
 and it 
was frequently regarded as being equivalent to, and was grouped together with Paneth cell 
metaplasia,
[45-47]
 considering their comparable biologic significance, although inaccurate in the 
strict sense. Paneth cell metaplasia/hyperplasia was found to be positively associated with crypt 
distortion and lymphoplasmacytic infiltration in lamina propria and related to the epithelial 
regeneration and repair.
[45,48]
 Here we noticed that UC patients with Paneth cell metaplasia had a 
significantly higher number of Th17 cells in colonic mucosa as compared with those without 
Paneth cell metaplasia. To our knowledge, the association or interaction between Paneth cells or 
Paneth cell metaplasia/hyperplasia and the adaptive immunity of gut mucosa is little known. Kamal 
et al reported Paneth cell increase in the small bowel of T. spiralis-infected mice, as a feature of 
innate mucosal defense, and the increase was modulated by a thymic-independent population of 
mucosal T cells.
[49]
Forsberg et al reported a correlation between the mRNA levels of IFN-γ in the 
intraepithelial lymphocytes and Paneth cell defensins in the duodenal mucosa in celiac disease. 
[50]
 
Recent studies also suggested a link between Paneth cells and Th17 cells. Salzman found in mice 
that the expression of human defensin (HD)-5 in small intestine resulted in a reduction of the Th17 
cells in lamina propria following the loss of segmented filamentous bacteria, suggesting that Paneth 
cell defensins can regulate the acquired immune responses through regulating the commensal 
microbiome.
[51, 52]
 On the other hand, Th17 cells in lamina propria were found to induce mucosal 
antimicrobial peptide expression, notably RegIIIγ, via IL-22 secretion.[53,54] Moreover, Paneth cell 
per se can produce IL-17 in response to TNF challenge.
[55]
 Based on all of the findings, it is our 
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hypothesis that our current finding regarding the association of Th17 cells with Paneth cell 
metaplasia may be explained by the disruption of intestinal microbiota, which occurs in IBD, that 
induce Paneth cell metaplasia and in the meantime require the increase of Th17 cells in lamina 
propria. 
The presence of epithelioid granuloma, a collection of macrophages and other inflammatory 
cells, is a relatively specific histologic feature of CD, although it is only seen in less than half of 
CD patients. The etiology and significance of granuloma in CD are still unclear. Mycobacterium 
paratuberculosis has been suggested by some observations to be the pathogen related to Crohn’s 
granuloma formation, but it has never been confirmed. On the other hand, limited studies have 
suggested that the granuloma formation is associated with Th1-shifted immune response, by 
showing immunohistochemically the increased expression of Th1-type cytokines (IFN-γ, IL-12) 
and accumulation of CCR5
+
 and CXCR3
+
 Th1 cells in colonic mucosa with Crohn’s 
granuloma.
[56,57]
 In our study, it was surprisingly revealed that the intestinal mucosa with Crohn’s 
granulomas had significantly increased prevalence of IL-22
+
 CD4
+ 
T cells as well as IL-22
+
IFN-γ+ 
CD4
+
 T cells, but not the typical Th1 cells, compared to that without granuloma. One possible 
explanation for the different results is the methodologic bias. The aforementioned studies used 
immunohistochemistry to reveal the abundance of Th1 cells in granuloma, which gave the absolute 
number of Th1 cells, not the percentage as in our study. Also, as mentioned above, IL-22 could be 
produced by Th1 cells as well. The association of granuloma with both IL-22
+
 and IL-22/IFN-γ 
double expressing CD4
+
 T cells may partly reflect the predominance and the pathogenic role of Th1 
cells in the granuloma formation in CD.  
Downloaded from https://academic.oup.com/ecco-jcc/advance-article-abstract/doi/10.1093/ecco-jcc/jjy116/5076882
by guest
on 27 August 2018
Ac
ce
pte
d M
an
us
cri
pt
Manuscript Doi: 10.1093/ecco-jcc/jjy116 
19 
 
The present study took the advantage of being the first study systemically analyzing the 
association between the histopathologic features and the immunologic abnormalities in colonic 
mucosa in IBD. However, there are some limitations in our study. First, the study focused on the 
large intestine only. Some biopsies were randomly taken, not site specific. Concurrent medications 
are likely to change the prevalence of CD4
+
 T cells in lamina propria. All these are confounding 
factors that should be taken into account in future study. Second, the immunological study was 
done by flow cytometry, which although a favored method to provide more information about the 
detailed immunotypes, was performed on different (though adjacent) pieces of mucosal tissue, 
instead of by direct immunohistochemical staining on the exactly same tissue as that for 
histological evaluation. Lastly, the possible relationship of certain Th subsets with certain 
histologic changes could only be postulated based on the quantitative correlation analysis.  
In conclusion, aberrant adaptive immunity appears to be associated with the patterns of 
histopathologic changes in intestinal mucosa in IBD. Treg cells is associated with the active 
inflammation, Th22 with the chronic crypt architecture alteration, and Th17 with the Paneth cell 
metaplasia/hyperplasia. These findings are novel and provide us with more insights about the 
pathogenesis of IBD. 
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Figure Legends 
 
Figure1. Examples of key histologic features of ‘Activity’ and ‘Chronicity’ of IBD. A. 
Neutrophil infiltration of surface epithelium. B. Neutrophilic cryptitis. C. Neutrophilic crypt 
abscess causing crypt destruction. D. Crypt architecture distortion. E. Paneth cell hyperplasia in the 
proximal colon. F. Epithelioid granuloma in CD.   
 
Figure 2. Examples of flowcytometry gating strategy for defining different CD4
+
 T cell 
subsets.  
 
Figure 3. Correlation of ECAP scores with RHI scores and D’Haens scores. Both total ECAP 
scores and ECAP category A scores are in parallel to the RHI scores in UC (A) and (B) as well as 
to D’Haens scores in CD (C to E).  
 
Figure 4. Correlation of Treg cells in lamina propria and histologic disease severity assessed 
in various histological scores. The proportion (%) of Treg (CD25
+
FoxP3
+
CD4
+
 T cells) in colonic 
lamina propria of both UC and CD patients were closely correlated with either total ECAP scores or 
RHI scores or D’Haens scores (A, B, D, E), as well as with the ECAP category A scores (C, F). 
The solid line in the middle in each graph is the 95% confidence interval. 
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Figure 5. Correlation of Treg cells in colonic lamina propria and individual histologic 
features of activity. The proportion of CD25
+
FoxP3
+
CD4
+
 Treg cells were associated with 
features of the subcategory A2 (neutrophilic cryptitis) (5-A), A3 (crypt abscess) (5-B), A4 (crypt 
destruction) (5-C), A6 (basal plasmacytosis) (5-D), A7 (lamina propria neutrophilic infiltration) (5-
E) in UC patients, and A1 (surface epithelial neutrophilic inflammation) (5-F) in CD patients. * p < 
0.05. 
 
Figure 6. Correlation of IL-17
+
 CD4
+
 cells and histologic features of UC. The proportion of 
IL17
+
 Th cells in colonic lamina propria was correlated with the presence of neutrophil infiltration 
in lamina propria (A7) (6-A) and Paneth cell metaplasia (C2) (6-C), whereas RoRc
+
 Th cells were 
correlated with the lamina propria mononuclear cell cellularity (A5) (6-B). * p < 0.05. 
 
Figure 7. Correlation of IL-22
+
 cells and Th-22 cells and histologic features of chronicity. 
Certain CD4
+
 T cell subsets in lamina propria were associated with some histologic features of 
chronicity.  UC with diffuse crypt architectural alteration (C1) had a higher percentage of IL-
22
+
CD4
+
T cells (7-A) as well as Th22 (IL-22
+
IL-17
-
IFN-γ-CD4+ T) cells (7-B) in lamina propria. 
Similarly, CD with diffuse crypt architectural alteration had a higher percentage of Th22 cells (7-
D and 7-E), and CD with granuloma had higher percentage of IL-22
+
CD4
+
 T cells (7-F). * p < 
0.05, ** p < 0.01. 
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Table 1. Demographic Data and Clinical Features of the Enrolled Patients 
 Ulcerative colitis 
(n=27) 
Crohn’s disease 
    (n=26) Male (n,%) 12 (44.4) 19 (73.1) 
Age (Mean± SD) 37.59 ± 11.96 43.9 ± 15.6 
Family history of IBD  6 (22.2)  1 (3.8) 
Disease type, n (%)   
 UC  Procitis  4 (14.3)  
      Left side colitis 12 (42.9)  
      pancolitis 11 (39.3)  
  CD  Colitis  21 (80.8) 
      Ileocolitis   5 (19.2) 
Disease Activity, n (%)   
UC  Remission  6 (21.4)  
Mild 11 (39.3)  
Moderate  8 (28.6)  
Severe*   2 (7.1)  
  CD  Remission  17 (65.4) 
Moderate   5 (19.2) 
      severe   4 (15.4) 
Endoscopic Index, n (%)   
Mayo 0-1 12 (48.1)  
Mayo 2 10 (35.7)  
Mayo 3  4 (14.3)  
SES-CD 0-2#   2 (7.7) 
SES-CD 3-6  17 (65.4) 
SES-CD 7-15   6 (23.1) 
SES-CD >16**   1 (3.8) 
Medications, n (%)    
5-ASA 10 (35.7)  7 (26.9) 
Corticosteroid  3 (10.7)  1 (3.8) 
AZA or MTX  7 (25.9)  5 (19.2) 
Anti-TNFα  7 (25.9)  5 (19.2) 
None  6 (22.2) 11 (42.3) 
Biopsy Sites, n (%)    
Rectum 11 (39.3)  4 (15.4) 
Sigmoid 11 (39.3) 11 (42.3) 
Descending colon  3 (10.7)  1 (3.8) 
Splenic flexure  0 (0)  0 (0) 
Transverse colon  0 (0)  2 (7.7) 
Hepatic flexure  0 (0)  2 (7.7) 
Ascending colon  2 (7.1)  5 (19.2) 
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*
 The moderate and severe active UC were later combined into ‘moderate to severe active UC’ for further analysis 
#
 The patients with SES-CD 0-2 and those with SES-CD 3-6 were later combined for further analysis 
**
 The patients with SES-CD >16 and those SES-CD 7-15 were later combined for further analysis 
 
  
Cecum  0 (0)  1 (3.8) 
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Table 2. IBD Histological Scoring Scheme (ECAP system) 
 
Histopathologic Features Score 
Extent of Inflammation (E) (for UC)  
None 0 
Focal 1 
Multifocal (Patchy) 2 
Diffuse 3 
Extent of Inflammation (E) (for CD)  
(% of Affected Biopsies)  
None 0 
≤25% 1 
>25% to ≤50% 2 
>50% to ≤75%  3 
>75% 4 
Chronicity (C)  
   C1. Crypt Architecture Alteration  
None 0 
Focal Alteration 1 
Patchy Distortion (<50%) 2 
Diffuse Distortion (>50%) 3 
   C2. Paneth Cell Metaplasia / Hyperplasia  
None 0 
Present 1 
Activity of Inflammation (A)  
   A1. Surface Epithelium  
Normal 0 
Reactive Changes (Mucin Depletion / Villiform) 1 
Neutrophilic infiltration / Probable Erosion 2 
Erosion 3 
Ulceration 4 
   A2. Neutrophilic Cryptitis  
None 0 
<5% 1 
<50% 2 
>50% 3 
   A3. Crypt Abscess  
None 0 
Present 1 
   A4. Crypt Destruction  
None 0 
Present 1 
   A5. Lamina Propria Mononuclear Cellularity  
Normal 0 
Mild Increase 1 
Moderate Increase 2 
Severe Increase 3 
   A6. Basal Plasmacytosis  
None 0 
Focal 1 
Diffuse 2 
   A7. Lamina Propria Neutrophilic Infiltration  
None 0 
Rare 1 
Scattered 2 
Extensive 3 
Plus / others (P)  
   P1. Lamina Propria Eosinophilic Infiltration  
None 0 
Mild 1 
Moderate 2 
Severe 3 
   P2. Lymphoid Follicles / Aggregates  
None 0 
Rare 1 
Prominent 2 
   P3. Granuloma (for CD only)  
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None 0 
Present 1 
Total ECAP Score  
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Figure 1. 
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Figure 2. 
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Figure 3. 
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Figure 4. 
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Figure 5. 
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Figure 6. 
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Figure 7. 
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